Sonic Healthcare Ltd
ASX:SHL

Watchlist Manager
Sonic Healthcare Ltd Logo
Sonic Healthcare Ltd
ASX:SHL
Watchlist
Price: 27.44 AUD 0.11% Market Closed
Market Cap: 13.2B AUD
Have any thoughts about
Sonic Healthcare Ltd?
Write Note

Net Margin
Sonic Healthcare Ltd

5.7%
Current
11%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
5.7%
=
Net Income
511.1m
/
Revenue
9B

Net Margin Across Competitors

Country AU
Market Cap 13.2B AUD
Net Margin
6%
Country US
Market Cap 75.6B EUR
Net Margin
1%
Country US
Market Cap 77.9B USD
Net Margin
1%
Country US
Market Cap 56B USD
Net Margin
1%
Country DE
Market Cap 26B EUR
Net Margin
3%
Country DE
Market Cap 18.9B EUR
Net Margin
-2%
Country US
Market Cap 19.3B USD
Net Margin
3%
Country US
Market Cap 17.7B USD
Net Margin
-2%
Country US
Market Cap 17.1B USD
Net Margin
9%
Country DE
Market Cap 13B EUR
Net Margin
3%
Country US
Market Cap 12.7B USD
Net Margin
7%
No Stocks Found

Sonic Healthcare Ltd
Glance View

Market Cap
13.2B AUD
Industry
Health Care
Economic Moat
None

Sonic Healthcare Ltd. began its journey in 1987, carved from a niche of independent pathology practices in Australia. It swiftly evolved into a global player, embracing a model that combines local expertise with the strength of an international network. The heart of Sonic's operations lies in its robust diagnostic services. Its laboratories process millions of tests each year, ensuring timely and accurate results across a spectrum of medical diagnostics, including pathology, radiology, and general practice medicine. This core service is augmented by state-of-the-art technology and a commitment to quality care, which has earned Sonic a reputation for reliability and excellence in the healthcare sector. Financially, Sonic Healthcare thrives on a business model that capitalizes on high volume and steady demand for medical diagnostic services. The company generates revenue through contracts with hospitals, clinics, and governments, providing essential health services that are non-discretionary and resilient, even in economic downturns. Growth is driven by strategic acquisitions and partnerships, which expand its footprint across regions like North America and Europe, ensuring a stream of diversified income. As healthcare spending continues to rise globally, Sonic Healthcare's business model remains well-positioned to leverage its international presence and expertise in diagnostic excellence, fueling sustainable growth and shareholder value over the long term.

SHL Intrinsic Value
32.22 AUD
Undervaluation 15%
Intrinsic Value
Price
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
5.7%
=
Net Income
511.1m
/
Revenue
9B
What is the Net Margin of Sonic Healthcare Ltd?

Based on Sonic Healthcare Ltd's most recent financial statements, the company has Net Margin of 5.7%.